State Board of Administration of Florida Retirement System held its stake in Core Laboratories NV (NYSE:CLB) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,356 shares of the company’s stock at the end of the second quarter. State Board of Administration of Florida Retirement System’s holdings in Core Laboratories NV were worth $292,000 at the end of the most recent quarter.
Several other large investors have also recently added to or reduced their stakes in the stock. MU Investments Co. Ltd. purchased a new stake in Core Laboratories NV during the second quarter valued at $115,000. CIBC World Markets Inc. purchased a new stake in Core Laboratories NV during the second quarter valued at $205,000. Creative Planning increased its stake in Core Laboratories NV by 19.8% in the second quarter. Creative Planning now owns 1,814 shares of the company’s stock valued at $225,000 after buying an additional 300 shares during the period. Dynamic Advisors Solutions LLC increased its stake in Core Laboratories NV by 5.6% in the second quarter. Dynamic Advisors Solutions LLC now owns 2,010 shares of the company’s stock valued at $249,000 after buying an additional 106 shares during the period. Finally, Schonfeld Strategic Advisors LLC purchased a new stake in Core Laboratories NV during the first quarter valued at $233,000.
Core Laboratories NV (NYSE:CLB) traded down 1.10% during trading on Friday, reaching $111.41. The company’s stock had a trading volume of 311,242 shares. Core Laboratories NV has a one year low of $84.50 and a one year high of $135.49. The firm has a market cap of $4.91 billion, a PE ratio of 59.10 and a beta of 1.45. The company has a 50-day moving average of $110.58 and a 200 day moving average of $117.47.
Core Laboratories NV (NYSE:CLB) last posted its quarterly earnings results on Wednesday, July 20th. The company reported $0.35 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.35. Core Laboratories NV had a net margin of 11.81% and a return on equity of 344.55%. The business earned $148.10 million during the quarter, compared to analyst estimates of $146.37 million. During the same period in the prior year, the business posted $0.81 earnings per share. The company’s revenue was down 27.4% on a year-over-year basis. Analysts expect that Core Laboratories NV will post $1.54 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, November 22nd. Shareholders of record on Friday, October 21st will be given a dividend of $0.55 per share. The ex-dividend date of this dividend is Wednesday, October 19th. This represents a $2.20 annualized dividend and a yield of 1.97%. Core Laboratories NV’s payout ratio is 117.65%.
Several research firms recently weighed in on CLB. Citigroup Inc. cut their price objective on Core Laboratories NV from $123.00 to $118.00 and set a “neutral” rating on the stock in a report on Monday, July 25th. DA Davidson began coverage on Core Laboratories NV in a research report on Wednesday, October 5th. They set a “buy” rating and a $136.00 target price for the company. Zacks Investment Research lowered Core Laboratories NV from a “buy” rating to a “hold” rating in a research report on Monday, September 26th. Credit Suisse Group AG began coverage on Core Laboratories NV in a research report on Thursday, September 1st. They set a “neutral” rating and a $115.00 target price for the company. Finally, Loop Capital began coverage on Core Laboratories NV in a research report on Friday, September 30th. They set a “hold” rating and a $120.00 target price for the company. Three analysts have rated the stock with a sell rating, eleven have assigned a hold rating and eight have assigned a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $121.61.
Core Laboratories NV Company Profile
Core Laboratories N.V. is a provider of reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company’s services and products are directed toward enabling the Company’s clients to improve reservoir performance and increase oil and gas recovery from their producing fields.
Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories NV (NYSE:CLB).
Receive News & Ratings for Core Laboratories NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories NV and related companies with MarketBeat.com's FREE daily email newsletter.